My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
August 2009
Vol. 19 No. 8
Patient Care and Science
Drug Approvals, Recalls, Adverse Events Update

IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content normally includes a range of topics, including new drug approvals and warnings. Recent alerts have included:

IDSA members can sign up for these services online. (You must be logged in to have access to this link.)


Is Your Facility Experiencing Antibiotic Shortages?
Report these to FDA and IDSA.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
Updated Guideline for Immunizations Released
IDSA/HIVMA Issue New Primary Care Guidelines for HIV
Seasonal & Pandemic Influenza 2009 Monograph Now Available
IDSA Journal Club on Vacation
Patient Care and Science
EIN: H1N1 Vaccine and Guillain-Barré Syndrome
Drug Approvals, Recalls, Adverse Events Update
Global ID
Global Center to Host Leading HIV/AIDS Physician-Scientist From South Africa
Congressional Efforts to Overhaul Foreign Assistance Raise Concerns
Policy and Advocacy
SHEA, IDSA Stress Basic Infection Control in Protecting HCWs from Novel H1N1
IDSA, HIVMA Outline Health Care Reform Priorities
Your Colleagues
Vote for the IDSA and HIVMA Boards of Directors
Members on the Move
Welcome, New Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.